Loading...
XHKG
1349
Market cap127mUSD
Dec 05, Last price  
2.92HKD
1D
-0.34%
1Q
-18.66%
Jan 2017
-54.94%
IPO
289.33%
Name

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd

Chart & Performance

D1W1MN
XHKG:1349 chart
P/E
22.69
P/S
1.28
EPS
0.12
Div Yield, %
3.34%
Shrs. gr., 5y
2.35%
Rev. gr., 5y
-7.37%
Revenues
702m
-17.49%
20,117,00019,764,00024,927,00031,990,00061,905,00092,390,000133,890,000232,527,000415,925,000470,900,000579,463,000621,870,000497,694,000740,422,0001,029,294,769833,802,6931,140,313,0881,031,159,838850,733,212701,965,887
Net income
40m
-63.42%
-30,356,000-22,030,000-29,550,000-23,402,000-7,320,0003,681,00030,826,00053,159,00087,218,000118,258,000127,723,000138,708,00075,287,000150,982,000227,357,983164,662,782213,295,758137,997,098108,627,36839,733,896
CFO
-15m
L
-21,399,000-17,185,000-15,890,0007,724,000-7,108,00049,589,000110,188,00089,442,00088,359,00096,296,000140,574,00042,711,000173,939,000269,232,612113,003,294268,899,775165,268,62271,015,450-14,770,410
Dividend
Jul 10, 20250.0321 HKD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

PFC Device Inc., together with its subsidiaries, engages in the research and development, design, manufacture, and sale of power discrete semiconductors under the PFC brand name in China, Hong Kong, Taiwan, and other Asian countries. It offers rectifiers, MOSFETs, IGBTs, bridge rectifiers, and packaging products for general power, consumer, industrial, and automotive applications. The company also provides power supply products; package products for mobile phone charger; and power supply applications for network and communication. In addition, it engages in investment and trade mark holding activities. The company was incorporated in 2016 and is headquartered in Chai Wan, Hong Kong. PFC Device Inc. is a subsidiary of Lotus Atlantic Limited.
URL
http://www.fd-zj.com
IPO date
Aug 13, 2002
Employees
138
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT